Logo Image

Video Shorts

Beau Webber, PhD
2:08
CISH Knockout TIL Therapy Using CRISPR Editing to Enhance T-Cell Function in GI Cancers
a year ago
by
Beau Webber, PhD
The Evolving Treatment Paradigm for Leukemia and Lymphoma
1:04
The Evolving Treatment Paradigm for Leukemia and Lymphoma
a year ago
by
Jorge Cortes, MD
The Importance of Early Recognition for Optimal Uterine Cancer Management
0:45
The Importance of Early Recognition for Optimal Uterine Cancer Management
a year ago
by
John Paul Diaz, MD
Sara M. Tolaney, MD, MPH, of Dana-Farber Cancer Institue
0:44
Rationale for Combining Sac-TMT With Pembrolizumab in HR+, HER2– Breast Cancer
a year ago
by
Sara M. Tolaney, MD, MPH
Narjust Florez, MD
0:41
The Importance of a Consensus Manuscript to Bridge Gaps in Lung Cancer
a year ago
by
Narjust Florez, MD
Paul Gellhaus, MD, discusses the importance of accurate diagnosis and effective management strategies to kick off Prostate Cancer Awareness Month
0:38
Common Disease, Critical Choices: Navigating Prostate Cancer Management
a year ago
by
Paul Gellhaus, MD
Christine Ann Garcia, MD, MPH
0:34
Challenges in Transitioning to Research for Hematology/Oncology Fellows
a year ago
by
Christine Ann Garcia, MD, MPH
Ashish Saxena, MD, PhD
0:40
Advice for Hematology/Oncology Fellows for Handling a New Cancer Diagnosis
a year ago
by
Ashish Saxena, MD, PhD
Fawzi F Abu Rous, MD, discusses the investigation of the PD-L1 and VEGF-targeted bispecific antibody ivonescimab in NSCLC.
0:34
Ongoing Development of Ivonescimab in NSCLC
a year ago
by
Fawzi F Abu Rous, MD
Geoffrey B. Pelz, MD
0:59
Minimally Invasive Surgery Should Be Carefully Explained to Patients With Lung Cancer
a year ago
by
Geoffrey B. Pelz, MD
Nisha Joseph, MD, and Hans Lee, MD, discuss the clinical significance of the FDA's approval of linvoseltamab for relapsed/refractory multiple myeloma.
1:24
FDA Approval of Linvoseltamab for Relapsed/Refractory Multiple Myeloma
a year ago
by
Nisha Joseph, MD(+1 more)
Connie Lai, MD, discusses a retrospective analysis comparing the use of post-induction treatment strategies for patients with metastatic colorectal cancer.
1:07
Retrospective Analysis of Post-Induction Treatment Strategies in mCRC
a year ago
by
Connie Lai, MD
Ignacio Blanco, MD, PhD, discusses the clinical significance of the EU approval of mirdametinib for NF1-associated neurofibromas.
0:43
EU Approval of Mirdametinib for NF1-Associated PNs
a year ago
by
Ignacio Blanco, MD, PhD
Breelyn Wilky, MD, discusses the prevalence of KIT mutations and development of treatment resistance in gastrointestinal stromal tumors.
0:38
KIT Mutations and Treatment Resistance in GIST: What You Need to Know
a year ago
by
Breelyn A. Wilky, MD
Jorge Cortes, MD
2:05
Positive Research Findings Have Shifted Historical Treatment Standards in Hematologic Malignancies
a year ago
by
Jorge Cortes, MD
Professor Timothy Elliott
2:46
Advances in Therapeutic Cancer Vaccines May Give Way to Cancer Prevention Strategies
a year ago
by
Professor Timothy Elliott
Shubham Pant, MD, MBBS
1:20
The Future of Vaccine Therapy for Targeting Micrometastatic Disease in Pancreatic Cancer
a year ago
by
Shubham Pant, MD, MBBS
David A. Braun, MD, PhD
0:39
Immune Checkpoint Expression Differences Shown Between Chromophobe RCC and Clear Cell RCC
a year ago
by
David A. Braun, MD, PhD